Unlocking Genetic Potential: The Role of Blastomere Biopsy Micropipettes in ICSI with Monash Biotech

Monash Biotech

February 23rd, 2024

"Blastomere Biopsy Micropipettes" play a crucial role in a specialized assisted reproductive technology (ART) procedure known as Intracytoplasmic Sperm Injection (ICSI), particularly during the process of blastomere biopsy.

What is Blastomere Biopsy Micropipette ?

Blastomere Biopsy Micropipettes are precision-engineered micro tools designed for extracting a single cell, known as a blastomere, from an early-stage embryo. These micropipettes are characterized by their microscopic size and precise construction, allowing delicate manipulation at the cellular level.

Why are they Used in ICSI ?

Blastomere Biopsy Micropipettes are employed in ICSI as part of pre-implantation genetic testing (PGT). PGT involves the examination of embryos for genetic abnormalities before they are selected for implantation. By extracting a blastomere using these micropipettes, clinicians can perform genetic analysis on the isolated cell to identify any chromosomal abnormalities or genetic disorders. This information is crucial for selecting embryos with a higher likelihood of successful implantation and a reduced risk of genetic conditions.

When are they Used ?

Blastomere Biopsy Micropipettes are used during the early stages of embryo development, typically on day 3 after fertilization. This timing allows for the extraction of a single blastomere without significantly compromising the developmental potential of the embryo. The genetic information obtained through this biopsy aids in the selection of embryos for transfer, increasing the chances of a healthy pregnancy.

How are they Used in ICSI ?

During ICSI, after the sperm is directly injected into the egg, the resulting embryo undergoes careful monitoring. When the embryo reaches the appropriate stage (usually the 6- to 8-cell stage), a Blastomere Biopsy Micropipette is delicately used to isolate a single cell from the embryo. This micropipette is precisely manipulated by skilled embryologists to ensure minimal disturbance to the embryo. The extracted blastomere is then subjected to genetic testing, and the information obtained guides clinicians in selecting embryos for implantation.

In summary, Blastomere Biopsy Micropipettes are indispensable tools in ICSI, facilitating the delicate extraction of a single cell for genetic analysis. This process enhances the precision and success of pre-implantation genetic testing, ultimately contributing to improved outcomes in assisted reproduction by aiding in the selection of embryos with the highest potential for a healthy pregnancy.